Biosino Bio-Technology and Science Incorporation (HKG:8247)
Hong Kong · Delayed Price · Currency is HKD 4.280
+0.190 (4.65%)
At close: Jan 30, 2026
HKG:8247 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -47.33 | -42.53 | -11.65 | 8.11 | -1.14 | 2.72 |
Depreciation & Amortization | 16.57 | 17.48 | 20.07 | 23.98 | 27.62 | 24.99 |
Other Amortization | 0.33 | 0.33 | 0.29 | 0.35 | 0.31 | 0.3 |
Loss (Gain) From Sale of Assets | 3.62 | 3.62 | 2.4 | 0.11 | 0.2 | -0.33 |
Asset Writedown & Restructuring Costs | 12.97 | 12.97 | 0.59 | - | 0.31 | - |
Loss (Gain) From Sale of Investments | - | - | - | 0.71 | 0.27 | -2.82 |
Loss (Gain) on Equity Investments | 0.42 | 0.42 | -12.35 | -6.53 | -1.57 | -2.13 |
Provision & Write-off of Bad Debts | 5.66 | 5.66 | 0.57 | 0.47 | -0.23 | 0.36 |
Other Operating Activities | 4.43 | -7.68 | -3.49 | 15.5 | 28.58 | -5.69 |
Change in Accounts Receivable | 52.59 | 52.59 | 35.14 | -8.53 | -2.63 | 16.67 |
Change in Inventory | 5.42 | 5.42 | -16.02 | -1.92 | -6.65 | -9.65 |
Change in Accounts Payable | -24.43 | -24.43 | -25.47 | -8.66 | 20.55 | 7.91 |
Change in Unearned Revenue | -0.07 | -0.07 | -0.76 | -1.63 | -0.93 | -1.03 |
Change in Other Net Operating Assets | -0.02 | -0.02 | 4.11 | 22.58 | -15.8 | -19.92 |
Operating Cash Flow | 30.17 | 23.75 | -6.56 | 44.53 | 48.89 | 11.37 |
Operating Cash Flow Growth | - | - | - | -8.93% | 329.91% | -63.72% |
Capital Expenditures | -20.39 | -12.39 | -16.35 | -16.34 | -3.74 | -13.76 |
Sale of Property, Plant & Equipment | 0.47 | 0.47 | 0.38 | 0.37 | 0.55 | 3.82 |
Divestitures | - | - | - | - | - | -30.67 |
Sale (Purchase) of Intangibles | -2.83 | -2.83 | -0.23 | -0.14 | -2.81 | -17.2 |
Investment in Securities | -0.55 | -0.55 | - | - | - | 31.25 |
Other Investing Activities | 13.9 | 3.46 | -1.5 | 14.98 | 0.22 | 10.61 |
Investing Cash Flow | -9.41 | -11.85 | -17.7 | -1.12 | -5.78 | -15.94 |
Long-Term Debt Issued | - | 149.95 | 143.87 | 161.41 | 178.89 | 218.54 |
Total Debt Issued | 149.95 | 149.95 | 143.87 | 161.41 | 178.89 | 218.54 |
Short-Term Debt Repaid | - | - | - | - | - | -1.38 |
Long-Term Debt Repaid | - | -148.12 | -144.73 | -187.04 | -212.34 | -185.13 |
Total Debt Repaid | -148.12 | -148.12 | -144.73 | -187.04 | -212.34 | -186.51 |
Net Debt Issued (Repaid) | 1.83 | 1.83 | -0.86 | -25.62 | -33.46 | 32.03 |
Common Dividends Paid | - | - | - | - | - | -1.13 |
Other Financing Activities | -11.27 | -8.88 | 11.11 | 14.87 | -10.57 | -10.41 |
Financing Cash Flow | -9.44 | -7.05 | 10.25 | -10.76 | -44.02 | 20.5 |
Foreign Exchange Rate Adjustments | -0.05 | -0.05 | 0.07 | 0.22 | -0.08 | -0.53 |
Net Cash Flow | 11.27 | 4.8 | -13.94 | 32.88 | -0.98 | 15.4 |
Free Cash Flow | 9.78 | 11.36 | -22.91 | 28.19 | 45.15 | -2.39 |
Free Cash Flow Growth | - | - | - | -37.56% | - | - |
Free Cash Flow Margin | 4.35% | 4.32% | -7.92% | 7.56% | 12.97% | -0.73% |
Free Cash Flow Per Share | 0.07 | 0.08 | -0.16 | 0.20 | 0.31 | -0.02 |
Cash Interest Paid | 8.88 | 8.88 | 5.4 | 6.13 | 10.57 | 10.41 |
Cash Income Tax Paid | 1.89 | 1.89 | 5.81 | 5.15 | 2.66 | 0.28 |
Levered Free Cash Flow | 15.46 | 12.18 | -11.9 | 44.77 | 20.58 | -36 |
Unlevered Free Cash Flow | 21.43 | 17.99 | -7.9 | 49.04 | 27.18 | -28.92 |
Change in Working Capital | 33.49 | 33.49 | -3 | 1.84 | -5.45 | -6.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.